...like an expedited route, as there was a fully listed shell with some cash" in Ruthigen Inc....

...completed its reverse merger with Ruthigen (see BioCentury, April 13). Pulmatrix Inc. (NASDAQ:PULM), Lexington, Mass. Ruthigen Inc....

...raised $10 million in a venture offering prior to completing its reverse merger with Ruthigen Inc. Ruthigen...

...to $11.80 in its first day of trading after it completed a reverse merger with Ruthigen Inc....

...Pulmatrix will reverse-merge with Ruthigen, with Pulmatrix shareholders owning 81% of the surviving entity. The newco...
...the close of the merger, which is expected this quarter. Pulmatrix Inc. , Lexington, Mass. Ruthigen Inc....

...lavages with RUT58-60 or saline and 1 lavage with RUT58-60 or saline above the fascia. Ruthigen...
...quarter and of 130 patients in the Phase II portion by the end of 1Q15. Ruthigen Inc....

...to start a 28-day, double-blind Phase I/II trial in 150 patients following an IDMC review. Ruthigen Inc....

...to $20.3 million. The company, which closed Friday at $6.30, has 4.8 million shares outstanding. Ruthigen Inc....

...3/26/14 $57.5 $168.2 $210.3 25% Horizon Discovery Group plc (LSE:HZD) 3/24/14 $66.0 $198.7 $227.5 14% Ruthigen Inc....

...that it made modifications to its corporate governance following the IPO of its former subsidiary, Ruthigen...
...of Ruthigen common stock, or about a 43% stake, based on shares outstanding immediately after Ruthigen's...
...management. Microcyn is a solution containing oxychlorine compounds. Oculus Innovative Sciences Inc. (NASDAQ:OCLS), Petaluma, Calif. Ruthigen Inc....